Hematopoietic colony-stimulating factors: New players in tumor-nerve interactions

Journal of Molecular Medicine

Volumn 89, Issue 4, 2011, Pages 321-329

  Stösser, Sebastian ^a   Schweizerhof, Matthias ^a   Kuner, Rohini ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Cancer pain; G CSF; GM CSF; Hyperalgesia; Peripheral sensitization

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR ANTAGONIST; E21R; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; HEMOPOIETIC GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; STAT PROTEIN; UNCLASSIFIED DRUG; VANILLOID RECEPTOR;

BONE METABOLISM; BONE PAIN; BONE STRUCTURE; CANCER PAIN; CYTOKINE RELEASE; DRUG EFFECT; HEMATOPOIETIC CELL; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; MOLECULAR INTERACTION; NOCICEPTION; NONHUMAN; OSTEOCLAST; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; REVIEW; SENSORY NERVE; SIGNAL TRANSDUCTION; SOLID TUMOR; TUMOR CELL;

ANIMALS; BONE AND BONES; HUMANS; INFLAMMATION; NEOPLASMS; NOCICEPTORS; PAIN; RECEPTORS, GRANULOCYTE COLONY-STIMULATING FACTOR; RECEPTORS, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; SIGNAL TRANSDUCTION;

EID: 79955786300     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-010-0697-z     Document Type: Review

References (77)

1. Portenoy RK, Lesage P (1999) Management of cancer pain. Lancet 353:1695-1700. doi:10.1016/S0140-6736(99)01310-0 (Pubitemid 29224537)
2. Mantyh PW (2006) Cancer pain and its impact on diagnosis, survival and quality of life. Nat Rev Neurosci 7:797-809. doi:10.1038/nrn1914 (Pubitemid 44435262)
3. Mantyh PW, Hunt SP (2004) Mechanisms that generate and maintain bone cancer pain. Novartis Found Symp 260:221-238, discussion 238-240, 277-229
4. Wacnik PW, Eikmeier LJ, Ruggles TR, Ramnaraine ML, Walcheck BK, Beitz AJ, Wilcox GL (2001) Functional interactions between tumor and peripheral nerve: morphology, algogen identification, and behavioral characterization of a new murine model of cancer pain. J Neurosci 21:9355-9366 (Pubitemid 33096879)
5. Hamilton JA (2008) Colony-stimulating factors in inflammation and autoimmunity. Nat Rev Immunol 8:533-544. doi:10.1038/ nri2356 (Pubitemid 351913679)
6. Schweizerhof M, Stosser S, Kurejova M, Njoo C, Gangadharan V, Agarwal N, Schmelz M, Bali KK, Michalski CW, Brugger S, Dickenson A, Simone DA, Kuner R (2009) Hematopoietic colony-stimulating factors mediate tumor-nerve interactions and bone cancer pain. Nat Med 15:802-807. doi:10.1038/nm.1976
7. Vairo G, Hamilton JA (1991) Signalling through CSF receptors. Immunol Today 12:362-369
8. Kaushansky K (2006) Lineage-specific hematopoietic growth factors. N Engl J Med 354:2034-2045. doi:10.1056/ NEJMra052706
9. Hucho T, Levine JD (2007) Signaling pathways in sensitization: toward a nociceptor cell biology. Neuron 55:365-376. doi:10.1016/j.neuron.2007.07.008 (Pubitemid 47126268)
10. Jin X, Morsy N, Winston J, Pasricha PJ, Garrett K, Akbarali HI (2004) Modulation of TRPV1 by nonreceptor tyrosine kinase, c-Src kinase. Am J Physiol Cell Physiol 287:C558-C563. doi:10.1152/ajpcell.00113.2004 (Pubitemid 38955247)
11. Basbaum AI, Bautista DM, Scherrer G, Julius D (2009) Cellular and molecular mechanisms of pain. Cell 139:267-284. doi:10.1016/j.cell.2009.09.028
12. Panopoulos AD, Watowich SS (2008) Granulocyte colonystimulating factor: molecular mechanisms of action during steady state and 'emergency' hematopoiesis. Cytokine 42:277-288. doi:10.1016/j.cyto.2008.03.002
13. Balonov K, Khodorova A, Strichartz GR (2006) Tactile allodynia initiated by local subcutaneous endothelin-1 is prolonged by activation of TRPV-1 receptors. Exp Biol Med Maywood 231:1165-1170 (Pubitemid 43845598)
14. Wong GY, Gavva NR (2009) Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics: Recent advances and setbacks. Brain Res Rev 60:267-277. doi:10.1016/j. brainresrev.2008.12.006
15. Bolcskei K, Helyes Z, Szabo A, Sandor K, Elekes K, Nemeth J, Almasi R, Pinter E, Petho G, Szolcsanyi J (2005) Investigation of the role of TRPV1 receptors in acute and chronic nociceptive processes using gene-deficient mice. Pain 117:368-376. doi:10.1016/j.pain.2005.06.024. (Pubitemid 41386528)
16. Szabo A, Helyes Z, Sandor K, Bite A, Pinter E, Nemeth J, Banvolgyi A, Bolcskei K, Elekes K, Szolcsanyi J (2005) Role of transient receptor potential vanilloid 1 receptors in adjuvantinduced chronic arthritis: in vivo study using gene-deficient mice. J Pharmacol Exp Ther 314:111-119. doi:10.1124/jpet.104. 082487 (Pubitemid 41058247)
17. Gavva NR, Treanor JJ, Garami A, Fang L, Surapaneni S, Akrami A, Alvarez F, Bak A, Darling M, Gore A, Jang GR, Kesslak JP, Ni L, Norman MH, Palluconi G, Rose MJ, Salfi M, Tan E, Romanovsky AA, Banfield C, Davar G (2008) Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans. Pain 136:202-210. doi:10.1016/j. pain.2008.01.024
18. Miao T, Wu D, Zhang Y, Bo X, Subang MC, Wang P, Richardson PM (2006) Suppressor of cytokine signaling-3 suppresses the ability of activated signal transducer and activator of transcription-3 to stimulate neurite growth in rat primary sensory neurons. J Neurosci 26:9512-9519. doi:10.1523/ JNEUROSCI.2160-06.2006 (Pubitemid 44396864)
19. Dziennis S, Alkayed NJ (2008) Role of signal transducer and activator of transcription 3 in neuronal survival and regeneration. Rev Neurosci 19:341-361
20. Ji RR, Baba H, Brenner GJ, Woolf CJ (1999) Nociceptive-specific activation of ERK in spinal neurons contributes to pain hypersensitivity. Nat Neurosci 2:1114-1119. doi:10.1038/16040 (Pubitemid 30126370)
21. Zhuang ZY, Xu H, Clapham DE, Ji RR (2004) Phosphatidylinositol 3-kinase activates ERK in primary sensory neurons and mediates inflammatory heat hyperalgesia through TRPV1 sensitization. J Neurosci 24:8300-8309. doi:10.1523/JNEURO SCI.2893-04.2004 (Pubitemid 39280809)
22. Pezet S, Spyropoulos A, Williams RJ, McMahon SB (2005) Activity-dependent phosphorylation of Akt/PKB in adult DRG neurons. Eur J Neurosci 21:1785-1797. doi:10.1111/j.1460- 9568.2005.04011.x (Pubitemid 40685859)
23. al-Aoukaty A, Giaid A, Sinoff C, Ho AD, Maghazachi AA (1994) Priming effects of granulocyte-macrophage colony-stimulating factor are coupled to cholera toxin-sensitive guanine nucleotide binding protein in human T lymphocytes. Blood 83:1299-1309 (Pubitemid 24062853)
24. Wang S, Dai Y, Fukuoka T, Yamanaka H, Kobayashi K, Obata K, Cui X, Tominaga M, Noguchi K (2008) Phospholipase C and protein kinase A mediate bradykinin sensitization of TRPA1: a molecular mechanism of inflammatory pain. Brain 131:1241-1251. doi:10.1093/brain/awn060
25. Taiwo YO, Levine JD (1991) Further confirmation of the role of adenyl cyclase and of cAMP-dependent protein kinase in primary afferent hyperalgesia. Neuroscience 44:131-135.
26. Ferreira SH, Nakamura M (1979) I - Prostaglandin hyperalgesia, a cAMP/Ca2+ dependent process. Prostaglandins 18:179-190 (Pubitemid 10226023)
27. Bhave G, Zhu W, Wang H, Brasier DJ, Oxford GS, RWt G (2002) cAMP-dependent protein kinase regulates desensitization of the capsaicin receptor (VR1) by direct phosphorylation. Neuron 35:721-731 (Pubitemid 35223031)
28. Fitzgerald EM, Okuse K, Wood JN, Dolphin AC, Moss SJ (1999) cAMP-dependent phosphorylation of the tetrodotoxin-resistant voltage-dependent sodium channel SNS. J Physiol 516(Pt 2):433-446 (Pubitemid 29204448)
29. Bhave G, Hu HJ, Glauner KS, Zhu W, Wang H, Brasier DJ, Oxford GS, RWt G (2003) Protein kinase C phosphorylation sensitizes but does not activate the capsaicin receptor transient receptor potential vanilloid 1 (TRPV1). Proc Natl Acad Sci USA 100:12480-12485. doi:10.1073/pnas.2032100100 (Pubitemid 37271585)
30. Woo DH, Jung SJ, Zhu MH, Park CK, Kim YH, Oh SB, Lee CJ (2008) Direct activation of transient receptor potential vanilloid 1 (TRPV1) by diacylglycerol (DAG). Mol Pain 4:42. doi:10.1186/ 1744-8069-4-42
31. Prescott ED, Julius D (2003) A modular PIP2 binding site as a determinant of capsaicin receptor sensitivity. Science 300:1284-1288. doi:10.1126/science. 1083646 (Pubitemid 36618238)
32. Morenilla-Palao C, Planells-Cases R, Garcia-Sanz N, Ferrer-Montiel A (2004) Regulated exocytosis contributes to protein kinase C potentiation of vanilloid receptor activity. J Biol Chem 279:25665-25672. doi:10.1074/jbc. M311515200 (Pubitemid 38756829)
33. Nishimura M, Kaku K, Azuno Y, Okafuji K, Inoue Y, Kaneko T (1992) Stimulation of phosphoinositol turnover and protein kinase C activation by granulocyte-macrophage colony-stimulating factor in HL-60 cells. Blood 80:1045-1051
34. Kang HK, Lee HY, Lee YN, Jo EJ, Kim JI, Kim GY, Park YM, Min DS, Yano A, Kwak JY, Bae YS (2004) Up-regulation of phospholipase Cgamma1 and phospholipase D during the differentiation of human monocytes to dendritic cells. Int Immunopharmacol 4:911-920. doi:10.1016/j.intimp.2004.04.001 (Pubitemid 38739096)
35. Veis N, Hamilton JA (1991) GM-CSF and IL-3 stimulate diacylglycerol generation in murine bone marrow-derived macrophages. Biochem Biophys Res Commun 179:586-591
36. Evans SW, Rennick D, Farrar WL (1987) Identification of a signal-transduction pathway shared by haematopoietic growth factors with diverse biological specificity. Biochem J 244:683-691
37. Baxter GT, Miller DL, Kuo RC, Wada HG, Owicki JC (1992) PKC epsilon is involved in granulocyte-macrophage colony-stimulating factor signal transduction: evidence from microphysiometry and antisense oligonucleotide experiments. Biochemistry 31:10950-10954
38. Numazaki M, Tominaga T, Toyooka H, Tominaga M (2002) Direct phosphorylation of capsaicin receptor VR1 by protein kinase Cepsilon and identification of two target serine residues. J Biol Chem 277:13375-13378. doi:10.1074/jbc.C200104200 (Pubitemid 34967929)
39. Khasar SG, Lin YH, Martin A, Dadgar J, McMahon T, Wang D, Hundle B, Aley KO, Isenberg W, McCarter G, Green PG, Hodge CW, Levine JD, Messing RO (1999) A novel nociceptor signaling pathway revealed in protein kinase C epsilon mutant mice. Neuron 24:253-260 (Pubitemid 29466163)
40. Hucho TB, Dina OA, Levine JD (2005) Epac mediates a cAMPto- PKC signaling in inflammatory pain: an isolectin B4(+) neuron-specific mechanism. J Neurosci 25:6119-6126. doi:10.1523/JNEUROSCI.0285-05.2005 (Pubitemid 40923478)
41. Wang C, Gu Y, Li GW, Huang LY (2007) A critical role of the cAMP sensor Epac in switching protein kinase signalling in prostaglandin E2-induced potentiation of P2X3 receptor currents in inflamed rats. J Physiol 584:191-203. doi:10.1113/jphy siol.2007.135616 (Pubitemid 47500548)
42. Corey SJ, Burkhardt AL, Bolen JB, Geahlen RL, Tkatch LS, Tweardy DJ (1994) Granulocyte colony-stimulating factor receptor signaling involves the formation of a three-component complex with Lyn and Syk protein-tyrosine kinases. Proc Natl Acad Sci USA 91:4683-4687 (Pubitemid 24177713)
43. Ward AC, Monkhouse JL, Csar XF, Touw IP, Bello PA (1998) The Src-like tyrosine kinase Hck is activated by granulocyte colony-stimulating factor (G-CSF) and docks to the activated G-CSF receptor. Biochem Biophys Res Commun 251:117-123. doi:10.1006/bbrc.1998.9441 (Pubitemid 28498073)
44. Kroger N, Renges H, Kruger W, Gutensohn K, Loliger C, Carrero I, Cortes L, Zander AR (2000) A randomized comparison of once versus twice daily recombinant human granulocyte colony- stimulating factor (filgrastim) for stem cell mobilization in healthy donors for allogeneic transplantation. Br J Haematol 111:761-765 (Pubitemid 32098912)
45. de la Rubia J, Martinez C, Solano C, Brunet S, Cascon P, Arrieta R, Alegre A, Bargay J, de Arriba F, Canizo C, Lopez J, Serrano D, Verdeguer A, Torrabadella M, Diaz MA, Insunza A, de la Serna J, Espigado I, Petit J, Martinez M, Benlloch L, Sanz M (1999) Administration of recombinant human granulocyte colony-stimulating factor to normal donors: results of the Spanish National Donor Registry. Spanish Group of Allo- PBT. Bone Marrow Transplant 24:723-728. doi:10.1038/sj. bmt.1701977 (Pubitemid 29469271)
46. De Placido S, Lauria R, Carlomagno C, Perrone F, De Laurentiis M, Gallo C, Martignetti A, Bellelli T, Limite G, Petrella G, Bianco AR (1999) The impact of schedule on acute toxicity and doseintensity of high-dose chemotherapy with epirubicin and cyclophosphamide plus colony stimulating factors in advanced breast cancer. Int J Oncol 15:339-346
47. Bonilla MA, Dale D, Zeidler C, Last L, Reiter A, Ruggeiro M, Davis M, Koci B, Hammond W, Gillio A et al (1994) Long-term safety of treatment with recombinant human granulocyte colonystimulating factor (r-metHuG-CSF) in patients with severe congenital neutropenias. Br J Haematol 88:723-730 (Pubitemid 24375786)
48. Froberg MK, Garg UC, Stroncek DF, Geis M, McCullough J, Brown DM (1999) Changes in serum osteocalcin and bonespecific alkaline phosphatase are associated with bone pain in donors receiving granulocyte-colony-stimulating factor for peripheral blood stem and progenitor cell collection. Transfusion 39:410-414 (Pubitemid 29181687)
49. Duda RJ Jr, O'Brien JF, Katzmann JA, Peterson JM, Mann KG, Riggs BL (1988) Concurrent assays of circulating bone Gla-protein and bone alkaline phosphatase: effects of sex, age, and metabolic bone disease. J Clin Endocrinol Metab 66:951-957
50. Mantyh PW, Clohisy DR, Koltzenburg M, Hunt SP (2002) Molecular mechanisms of cancer pain. Nat Rev Cancer 2:201-209. doi:10.1038/nrc747 (Pubitemid 37328789)
51. Fulfaro F, Casuccio A, Ticozzi C, Ripamonti C (1998) The role of bisphosphonates in the treatment of painful metastatic bone disease: a review of phase III trials. Pain 78:157-169 (Pubitemid 29052273)
52. Carvalho B, Clark DJ, Angst MS (2008) Local and systemic release of cytokines, nerve growth factor, prostaglandin E2, and substance P in incisional wounds and serum following cesarean delivery. J Pain 9:650-657. doi:10.1016/j. jpain.2008.02.004
53. Angst MS, Clark JD, Carvalho B, Tingle M, Schmelz M, Yeomans DC (2008) Cytokine profile in human skin in response to experimental inflammation, noxious stimulation, and administration of a COX-inhibitor: a microdialysis study. Pain 139:15-27. doi:10.1016/j.pain.2008.02.028
54. Liang D, Shi X, Qiao Y, Angst MS, Yeomans DC, Clark JD (2008) Chronic morphine administration enhances nociceptive sensitivity and local cytokine production after incision. Mol Pain 4:7. doi:10.1186/1744-8069-4-7 (Pubitemid 351513131)
55. Feldmann M, Brennan FM, Maini RN (1996) Rheumatoid arthritis. Cell 85:307-310 (Pubitemid 26160702)
56. Kokkonen H, Soderstrom I, Rocklov J, Hallmans G, Lejon K, Rantapaa Dahlqvist S (2010) Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis. Arthritis Rheum 62:383-391. doi:10.1002/art.27186
57. Hitchon CA, Alex P, Erdile LB, Frank MB, Dozmorov I, Tang Y, Wong K, Centola M, El-Gabalawy HS (2004) A distinct multicytokine profile is associated with anti-cyclical citrullinated peptide antibodies in patients with early untreated inflammatory arthritis. J Rheumatol 31:2336-2346 (Pubitemid 39603079)
58. Cook AD, Braine EL, Campbell IK, Rich MJ, Hamilton JA (2001) Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease. Arthritis Res 3:293-298 (Pubitemid 32821522)
59. Eyles JL, Hickey MJ, Norman MU, Croker BA, Roberts AW, Drake SF, James WG, Metcalf D, Campbell IK, Wicks IP (2008) A key role for G-CSF-induced neutrophil production and trafficking during inflammatory arthritis. Blood 112:5193-5201. doi:10.1182/blood-2008-02-139535
60. Lawlor KE, Campbell IK, Metcalf D, O'Donnell K, van Nieuwenhuijze A, Roberts AW, Wicks IP (2004) Critical role for granulocyte colony-stimulating factor in inflammatory arthritis. Proc Natl Acad Sci USA 101:11398-11403. doi:10.1073/ pnas.0404328101 (Pubitemid 39038358)
61. Cornish AL, Campbell IK, McKenzie BS, Chatfield S, Wicks IP (2009) G-CSF and GM-CSF as therapeutic targets in rheumatoid arthritis. Nat Rev Rheumatol 5:554-559. doi:10.1038/ nrrheum.2009.178
62. Andratsch M, Mair N, Constantin CE, Scherbakov N, Benetti C, Quarta S, Vogl C, Sailer CA, Uceyler N, Brockhaus J, Martini R, Sommer C, Zeilhofer HU, MullerW, Kuner R, Davis JB, Rose-John S, Kress M (2009) A key role for gp130 expressed on peripheral sensory nerves in pathological pain. J Neurosci 29:13473-13483. doi:10.1523/JNEUROSCI.1822-09.2009
63. Honore P, Luger NM, Sabino MA, Schwei MJ, Rogers SD, Mach DB, O'Keefe PF, Ramnaraine ML, Clohisy DR, Mantyh PW (2000) Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord. Nat Med 6:521-528 (Pubitemid 30305901)
64. Wacnik PW, Eikmeier LJ, Simone DA, Wilcox GL, Beitz AJ (2005) Nociceptive characteristics of tumor necrosis factoralpha in naive and tumor-bearing mice. Neuroscience 132:479-491 (Pubitemid 40417919)
65. Constantin CE, Mair N, Sailer CA, Andratsch M, Xu ZZ, Blumer MJ, Scherbakov N, Davis JB, Bluethmann H, Ji RR, Kress M (2008) Endogenous tumor necrosis factor alpha (TNFalpha) requires TNF receptor type 2 to generate heat hyperalgesia in a mouse cancer model. J Neurosci 28:5072-5081. doi:10.1523/ JNEUROSCI.4476-07.2008
66. Dedhar S, Gaboury L, Galloway P, Eaves C (1988) Human granulocyte-macrophage colony-stimulating factor is a growth factor active on a variety of cell types of nonhemopoietic origin. Proc Natl Acad Sci USA 85:9253-9257 (Pubitemid 19001875)
67. Danis VA, Franic GM, Rathjen DA, Brooks PM (1991) Effects of granulocyte-macrophage colony-stimulating factor (GMCSF), IL-2, interferon-gamma (IFN-gamma), tumour necrosis factor-alpha (TNF-alpha) and IL-6 on the production of immunoreactive IL-1 and TNF-alpha by human monocytes. Clin Exp Immunol 85:143-150
68. Xu WD, Firestein GS, Taetle R, Kaushansky K, Zvaifler NJ (1989) Cytokines in chronic inflammatory arthritis. II Granulocyte macrophage colony stimulating factor rheumatoid synovial effusions. J Clin Invest 83:876-882 (Pubitemid 19080619)
69. Sisson SD, Dinarello CA (1988) Production of interleukin-1 alpha, interleukin-1 beta and tumor necrosis factor by human mononuclear cells stimulated with granulocyte-macrophage colony-stimulating factor. Blood 72:1368-1374 (Pubitemid 18265906)
70. Seelentag W, Mermod JJ, Vassalli P (1989) Interleukin 1 and tumor necrosis factor-alpha additively increase the levels of granulocyte-macrophage and granulocyte colony-stimulating factor (CSF) mRNA in human fibroblasts. Eur J Immunol 19:209-212 (Pubitemid 19069312)
71. Nelson J, Bagnato A, Battistini B, Nisen P (2003) The endothelin axis: emerging role in cancer. Nat Rev Cancer 3:110-116. doi:10.1038/nrc990 (Pubitemid 37328878)
72. Salh B, Hoeflick K, Kwan W, Pelech S (1998) Granulocytemacrophage colony-stimulating factor and interleukin-3 potentiate interferon-gamma-mediated endothelin production by human monocytes: role of protein kinase C. Immunology 95:473-479 (Pubitemid 28505706)
73. Owen JL, Lopez DM, Grosso JF, Guthrie KM, Herbert LM, Torroella-Kouri M, Iragavarapu-Charyulu V (2005) The expression of CCL2 by T lymphocytes of mammary tumor bearers: role of tumor-derived factors. Cell Immunol 235:122-135 (Pubitemid 41597476)
74. Khasabova IA, Stucky CL, Harding-Rose C, Eikmeier L, Beitz AJ, Coicou LG, Hanson AE, Simone DA, Seybold VS (2007) Chemical interactions between fibrosarcoma cancer cells and sensory neurons contribute to cancer pain. J Neurosci 27:10289-10298 (Pubitemid 47450473)
75. Hansen G, Hercus TR, McClure BJ, Stomski FC, Dottore M, Powell J, Ramshaw H, Woodcock JM, Xu Y, Guthridge M, McKinstry WJ, Lopez AF, Parker MW (2008) The structure of the GM-CSF receptor complex reveals a distinct mode of cytokine receptor activation. Cell 134:496-507
76. Hercus TR, Bagley CJ, Cambareri B, Dottore M, Woodcock JM, Vadas MA, Shannon MF, Lopez AF (1994) Specific human granulocyte-macrophage colony-stimulating factor antagonists. Proc Natl Acad Sci USA 91:5838-5842 (Pubitemid 24188237)
77. Olver IN, Hercus T, Lopez A, Vadas M, Somogyi AA, Doyle I, Foster DJ, Keefe D, Taylor A, Brown M, To LB, Cole J, Rawling T, Cambareri B, Myers M, Olszewski N, Bastiras S, Senn C, Hey A, Verma M, Wigley P (2002) A phase I study of the GM-CSF antagonist E21R. Cancer Chemother Pharmacol 50:171-178. doi:10.1007/s00280-002-0474-y (Pubitemid 35013654)